Search results
Results from the WOW.Com Content Network
The Trifecta (TM) Valve. (Photo: St. Jude Medical, Inc.) Conducted at 31 medical centers in the U.S., Canada and Europe, the study followed 1,014 eligible patients implanted with the Trifecta ...
The Food and Drug Administration has announced on its website that medical device maker St. Jude Medical last month recalled a device used in heart surgery because of the risk that it could cause ...
In the US, UK and the European Union, the most common type of artificial heart valve is the bioprosthetic valve. Mechanical valves are more commonly used in Asia and Latin America. [citation needed] Companies that manufacture heart valves include Edwards Lifesciences, [5] Medtronic, [6] Abbott (St. Jude Medical), [7] CryoLife, [8] and LifeNet ...
St. Jude Medical was founded in 1976 to further develop bi-leaflet artificial heart valves, which were originally created in 1972 at the University of Minnesota. [4] [5] St. Jude Medical's bi-leaflet valve was developed in large part by Dr. Demetre Nicoloff of the University of Minnesota and St. Jude Medical employee Don Hanson.
FDA's role under the guidelines is to monitor company recalls and assess the adequacy of a firm's action. After a recall is completed, FDA makes sure that the product is destroyed or suitably reconditioned and investigates why the product was defective. Generally, FDA accepts reports and other necessary recall information submitted by e-mail.
Another piece of bad news has come out for St. Jude Medical (NYS: STJ) regarding an FDA report on defibrillator lead Durata, bringing shares down 12%. In this video, Motley Fool health-care ...
St. Jude Children's Research Hospital is a pediatric treatment and research hospital headquartered in Memphis, Tennessee. Founded by entertainer Danny Thomas in 1962, it is a 501(c)(3) designated nonprofit medical corporation which focuses on children's catastrophic diseases, particularly leukemia and other cancers. [ 1 ]
The hits keep on coming for St. Jude Medical . Fresh off earnings that showed the continued decline of its cardiac rhythm management, or CRM, sales, St. Jude took a fresh cardio kick this week ...